V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20167167 | 20063829 | 1.54 | 96 | Palliative (P) | 2019-10-09 | 2019-10-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101107278 |
| 20167171 | 20063830 | 1.81 | 90 | null | 2019-06-04 | 2019-06-06 | ECX | N | N | ECX | 100745774 |
| 20167172 | 20063831 | 1.7 | 64.8 | Adjuvant (A) | 2016-06-22 | 2016-06-23 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100023349 |
| 20167175 | 20063832 | 1.54 | 73 | Palliative (P) | 2019-03-05 | 2019-03-23 | ECX | N | N | ECX | 101687800 |
| 20167177 | 20063833 | null | null | Curative (C) | 2016-08-29 | 2016-09-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100718199 |
| 20167190 | 20063834 | 1.61 | 69.7 | Palliative (P) | 2019-12-31 | 2019-12-31 | ECX | N | null | ECX | 101250650 |
| 20167196 | 20063835 | 1.63 | 83 | Adjuvant (A) | 2018-12-03 | 2018-12-11 | ECX | 02 | N | ECX | 101594700 |
| 20167197 | 20063836 | 1.61 | 93.7 | Palliative (P) | 2016-10-03 | 2016-10-06 | ECX | 2 | null | ECX | 100173162 |
| 20167198 | 20063837 | 1.78 | 53.8 | Neo-adjuvant (N) | 2017-07-31 | 2017-08-01 | ECX | N | N | ECX | 100683815 |
| 20167199 | 20063838 | 1.8 | 95.3 | Adjuvant (A) | 2017-11-30 | 2017-11-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100938667 |
| 20167202 | 20063839 | 1.6 | 63.4 | Neo-adjuvant (N) | 2019-05-22 | 2019-05-24 | ECX | N | N | ECX | 101590043 |
| 20167207 | 20063840 | 1.98 | 57.9 | Adjuvant (A) | 2017-08-07 | 2017-08-08 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100037475 |
| 20167209 | 20063841 | 1.66 | 73.1 | Palliative (P) | 2016-12-03 | 2016-12-12 | ECX | N | N | ECX | 101080873 |
| 20167211 | 20063842 | 1.66 | 85.4 | Palliative (P) | 2018-01-13 | 2018-01-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100684672 |
| 20167212 | 20063843 | 1.51 | 59.9 | Palliative (P) | 2019-05-24 | 2019-06-14 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100420669 |
| 20167215 | 20063844 | 1.57 | 64.35 | Neo-adjuvant (N) | 2019-09-22 | 2019-09-25 | ECX | N | N | ECX | 101507185 |
| 20167218 | 20063845 | 1.57 | 65.7 | Neo-adjuvant (N) | 2016-01-18 | 2016-02-03 | ECX | 02 | N | ECX | 100351214 |
| 20167225 | 20063846 | 1.6 | 52.8 | Palliative (P) | 2018-12-03 | 2018-12-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100420118 |
| 20167228 | 20063847 | 1.89 | 55.4 | Adjuvant (A) | 2018-02-04 | 2018-02-05 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100543686 |
| 20167232 | 20063848 | 1.56 | 84.6 | Palliative (P) | 2018-08-01 | 2018-08-11 | ECX | N | N | ECX | 100334173 |
| 20167244 | 20063849 | 1.7 | 95.7 | Neo-adjuvant (N) | 2017-07-03 | 2017-07-09 | ECX | N | N | ECX | 101154884 |
| 20167257 | 20063850 | 1.7 | 70.5 | Neo-adjuvant (N) | 2016-03-08 | 2016-03-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100647761 |
| 20167260 | 20063851 | 1.6 | 46 | Palliative (P) | 2017-09-12 | 2017-09-28 | ECX | 2 | N | ECX | 100165971 |
| 20167262 | 20063852 | 1.68 | 78 | Adjuvant (A) | 2019-03-25 | 2019-04-10 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101317766 |
| 20167267 | 20063853 | 1.73 | 58.4 | Palliative (P) | 2019-06-30 | 2019-06-30 | ECX | N | N | ECX | 101202313 |
| 20167270 | 20063854 | 1.53 | 64 | Neo-adjuvant (N) | 2018-07-07 | 2018-07-07 | ECX | N | null | ECX | 100031617 |
| 20167274 | 20063855 | 1.7 | 61 | Adjuvant (A) | 2017-04-11 | 2017-05-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100340613 |
| 20167276 | 20063856 | 1.72 | 45.4 | null | 2016-12-18 | 2017-01-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100621411 |
| 20167282 | 20063857 | 1.69 | 85.4 | Palliative (P) | 2018-02-13 | 2018-03-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100391080 |
| 20167286 | 20063858 | 1.64 | 68.5 | Neo-adjuvant (N) | 2019-08-21 | 2019-08-21 | ECX | N | N | ECX | 100306578 |
| 20167287 | 20063859 | 1.6 | 65.2 | 03 | 2018-11-16 | 2018-11-25 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100169127 |
| 20167305 | 20063860 | 1.72 | 81.6 | Palliative (P) | 2018-02-21 | 2018-03-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101541230 |
| 20167307 | 20063861 | 1.72 | 76 | Adjuvant (A) | 2016-05-01 | 2016-05-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101110332 |
| 20167311 | 20063862 | 1.67 | 52.4 | Palliative (P) | 2018-03-04 | 2018-03-18 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101470111 |
| 20167312 | 20063863 | 1.55 | 103.6 | Palliative (P) | 2016-12-13 | 2016-12-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100810315 |
| 20167313 | 20063864 | 1.79 | 61 | Neo-adjuvant (N) | 2017-10-04 | 2017-10-05 | ECX | 2 | null | ECX | 100313637 |
| 20167319 | 20063865 | 1.62 | 80 | Palliative (P) | 2020-02-21 | 2020-03-09 | ECX | 02 | N | ECX | 100910531 |
| 20167321 | 20063866 | 1.77 | 63.2 | Curative (C) | 2019-06-29 | 2019-07-26 | ECX | N | N | ECX | 101613735 |
| 20167322 | 20063867 | 1.7 | 78.7 | Adjuvant (A) | 2016-05-16 | 2016-06-11 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100308125 |
| 20167329 | 20063868 | 1.71 | 68.2 | 02 | 2019-05-13 | 2019-05-15 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100826478 |
| 20167331 | 20063869 | 1.7 | 96 | Adjuvant (A) | 2018-09-05 | 2018-10-04 | ECX | 02 | null | ECX | 101578394 |
| 20167341 | 20063870 | 1.77 | 91 | Neo-adjuvant (N) | 2016-07-05 | 2016-07-18 | ECX | 02 | N | ECX | 100219527 |
| 20167342 | 20063871 | 1.57 | 61.3 | Adjuvant (A) | 2016-10-16 | 2016-10-30 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100615689 |
| 20167343 | 20063872 | 1.59 | 125.15 | Neo-adjuvant (N) | 2016-09-13 | 2016-09-26 | ECX | 02 | N | ECX | 100508279 |
| 20167349 | 20063873 | 1.68 | 73.35 | Neo-adjuvant (N) | 2018-06-01 | 2018-06-13 | ECX | null | null | ECX | 100907480 |
| 20167351 | 20063874 | 1.58 | 82.9 | Adjuvant (A) | 2017-01-29 | 2017-01-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101733343 |
| 20167352 | 20063875 | 1.61 | 75.3 | null | 2018-08-22 | 2018-08-28 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101852017 |
| 20167355 | 20063876 | 1.6 | 96.1 | Palliative (P) | 2018-01-06 | 2018-01-11 | ECX | N | N | ECX | 100231555 |
| 20167356 | 20063877 | 1.62 | 60 | Neo-adjuvant (N) | 2019-07-09 | 2019-08-04 | ECX | 02 | N | ECX | 100364549 |
| 20167364 | 20063878 | 1.69 | 92.3 | Neo-adjuvant (N) | 2016-04-19 | 2016-04-21 | ECX | N | N | ECX | 100928897 |